Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLINUVEL PHARMACEUTICALS LIMITED Director's Dealing 2012

Oct 2, 2012

64726_rns_2012-10-02_794a6b5d-e82f-4809-87d3-8c04fcf2db9c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity CLINUVEL PHARMACEUTICALS LTD ABN 88 089 644 119

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director Dr Helmer (Hank) Agersborg
Date of last notice 22 December 2010
Date that director ceased to be director 26 September 2012

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

92,111 Ordinary Shares 300,000 Conditional Performance Rights

  • See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of Number & class of securities interest Note: Provide details of the circumstances giving rise to the relevant interest ACN 108 768 896 Pty Ltd – 150,000 Ordinary Shares (Beneficially held in the Clinuvel Conditional Rights Scheme Trust)

Part 3 – Director’s interests in contracts

==> picture [406 x 158] intentionally omitted <==

----- Start of picture text ----- Detail of contractNature of interestName of registered holder(if issued securities)No. and class of securities towhich interest relates----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002